z-logo
open-access-imgOpen Access
Can ivermectin mass drug administrations to control scabies also reduce skin and soft tissue infections? Hospitalizations and primary care presentations lower after a large-scale trial in Fiji
Author(s) -
Jo Middleton
Publication year - 2022
Publication title -
the lancet regional health - western pacific
Language(s) - English
Resource type - Journals
ISSN - 2666-6065
DOI - 10.1016/j.lanwpc.2022.100454
Subject(s) - scabies , ivermectin , medicine , soft tissue , drug , primary care , dermatology , intensive care medicine , surgery , veterinary medicine , family medicine , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom